7% Hypertonic Saline (HS) ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	3

299. 嚢胞性線維症

---

臨床試験数 : 1,696 /  薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02378467 (ClinicalTrials.gov)	March 1, 2015	27/2/2015	Saline Hypertonic in Preschoolers	Saline Hypertonic in Preschoolers	Cystic Fibrosis	Drug: 7% Hypertonic Saline (HS);Drug: 0.9% Isotonic Saline (IS)	University of Washington, the Collaborative Health Studies Coordinating Center	Cystic Fibrosis Foundation	Completed	3 Years	5 Years	All	150	N/A	United States;Canada
2	NCT00709280 (ClinicalTrials.gov)	April 2009	1/7/2008	Infant Study of Inhaled Saline in Cystic Fibrosis	Infant Study of Inhaled Saline in Cystic Fibrosis	Cystic Fibrosis	Drug: 7% Hypertonic Saline (HS);Drug: 0.9% Isotonic Saline (IS)	CF Therapeutics Development Network Coordinating Center	Cystic Fibrosis Foundation Therapeutics;National Heart, Lung, and Blood Institute (NHLBI)	Completed	4 Months	59 Months	Both	321	N/A	United States;Canada
3	NCT00546663 (ClinicalTrials.gov)	September 2007	17/10/2007	Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis	A Pilot Study to Evaluate the Tolerability of Inhaled 7% Hypertonic Saline in Infants With Cystic Fibrosis	Cystic Fibrosis	Drug: inhaled 7% hypertonic saline (HS)	CF Therapeutics Development Network Coordinating Center	Cystic Fibrosis Foundation Therapeutics	Completed	12 Months	30 Months	Both	19	N/A	United States;Canada